BioSpace News Archive

Histogen Inc. (NASDAQ: HSTO), a clinical-stage therapeutics company focused on developing potential first-in-class restorative therapeutics that ignite the body’s natural process to repair and maintain healthy biological function and its partner, Amerimmune, LLC, today reported the publication of the potential utility of emricasan in COVID-19 in Allergy, the official Journal of the European Academy of Allergy and Clinical Immunology.

FDA Agreed that a Single Pivotal Phase 3 Study is Sufficient for Potential Approval of D-PLEX 100 for the Prevention of Surgical Site Infections in Colorectal Surgery. Enrollment in Phase 3 SHIELD I Trial of D-PLEX 100 in Abdominal Surgery Continues to Advance ; Over 200 Patients Enrolled to Date Top-line Results Expected by Year-end

Shoreline Biosciences, Inc. , today announced the appointment of Kimber Manhard as a member of the Board of Directors

BioLife Solutions , Inc. (Nasdaq: BLFS) (“BioLife” or the “Company”), a leading developer and supplier of class-defining bioproduction products and services for cell and gene therapies and the broader biopharma market, today announced the promotion of Caitlin Rice to the leadership position of Global Vice President, Customer Service

HAVN Life Sciences Inc., a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural health products, is pleased to announce a production and supply agreement with Lobe Sciences Ltd., an innovative biotech company committed to investigating and developing treatments using psychedelic and non-traditional medicines for better brain health.

Halberd Corporation was featured in a recent MarketWatch article, “New Approaches to Covid-19 Treatment Enter the Picture,” along with six other notable biotechnology companies.

Nxt-ID, Inc. (NASDAQ: NXTD ) (the “Company” or “Nxt-ID”), a provider of technology products and services for healthcare applications, announces financial results for the three months ended March 31, 2021.

With Ultrasound App release V8.0, Clarius is reinventing the clinical experience by automating new workflows, refining high-definition imaging and empowering users to master ultrasound scanning. [19-May-2021] VANCOUVER, BC , May 19, 2021 /PRNewswire/ -- In its biggest Clarius Ultrasound App update to date, Clarius Mobile Health is introducing the ability for its wir

Jaguar Health, Inc. (NASDAQ:JAGX) today announced that the Company recently launched a new social media channel for stakeholders and the Companys growing community of followers. The Jaguar Health Community Instagram page will serve as a central social media communications hub

Cerner Corporation, a global health care technology company, announced that its Board of Directors declared a cash dividend to stockholders of $0.22 per issued and outstanding share.